[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100467042":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":46,"collaborators":7,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":7,"enrollmentInfo":59,"targetDuration":7,"studyType":62,"phases":7,"briefSummary":63,"conditions":64,"keywords":70,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"University Hospital, Limoges","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Marilyne DEBETTE-GRATIEN, MD","Hôpital Dupuytren","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","33 5 55 05 87 26","MARILYNE.GRATIEN@chu-limoges.fr",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Véronique LOUSTAUD-RATTI, Prof","33 5 55 05 66 84","veronique.loustaud-ratti@unilim.fr",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Chu Limoges","RECRUITING","Limoges","Haute Vienne","87042","France","FR",{"type":32,"coordinates":33},"Point",[34,35],1.24759,45.83362,{"lat":35,"lon":34},[38,42],{"name":39,"role":15,"phone":40,"phoneExt":7,"email":41},"FRANCOIS Sandrine, PhD","33 5 19 76 17 66","sandrine.francois@chu-limoges.fr",{"name":43,"role":15,"phone":44,"phoneExt":7,"email":45},"Céline RIGAUD, MSc","33 5 55 05 60 52","celine.rigaud@chu-limoges.fr",{"type":47,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100467042","acceptability-of-simultaneous-screening-for-viral-hepatitis-b-c-and-hiv-among-drug-users-in-non-conventional-structures-100467042",false,"NCT05361603","Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures","Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities \"Outside the Walls\" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan","SCANVIR","Inclusion Criteria:\n\n* Adult 18 and over\n* Patient frequenting an unconventional structure \"outside the walls\" or referred by a professional in the care sector\n* Patient who agreed to participate to the research\n\nExclusion Criteria:\n\n* Patient doesn't agree to participate to the research",true,"ALL","18 Years",{"count":60,"type":61},1500,"ESTIMATED","OBSERVATIONAL","The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.",[65,66,67,68,69],"Hepatitis C","Transmission, Intravenous Drug Abuser","Addiction, Alcohol","Addiction Opiate","Hepatitis C Virus Infection, Response to Therapy of",[71,72,73,74,75,76,77],"hepatitis C","Elimination","HBV","HIV","PWID","Addiction","Care structure","2022-05-03",{"date":80,"type":81},"2022-05-04","ACTUAL",{"date":83,"type":81},"2017-05-24",{"date":85,"type":61},"2030-02-14",{"name":5,"class":6},1]